Success in control of hypertension in a low-resource setting: The Cuban experience

Journal of Hypertension

Volumn 24, Issue 5, 2006, Pages 845-849

  Orduñez Garcia, Pedro ^a   Bernal Munoz, Jose Luis ^a   Pedraza, Dania ^b   Espinosa Brito, Alfredo ^a   Silva, Luis Carlos ^c   Cooper, Richard S ^d  

^a Hospital Universitario Dr Gustavo Aldereguia Lima   (Cuba)

^b Cienfuegos Municipal Health Department   (Cuba)

^c INSTITUTO SUPERIOR DE CIENCIAS MÉDICAS DE LA HABANA   (Cuba)

^d LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Cuba; Hypertension; Low resource setting; Treatment

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADOLESCENT; ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CARDIOVASCULAR DISEASE; CUBA; DEVELOPING COUNTRY; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; EARLY DIAGNOSIS; FEASIBILITY STUDY; FEMALE; HEALTH CARE SYSTEM; HEALTH SURVEY; HUMAN; HYPERTENSION; LOW RESOURCE SETTING; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RISK REDUCTION; SYSTOLIC BLOOD PRESSURE;

EID: 33646362291     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000222753.67572.28     Document Type: Article

References (24)

1. Beaglehole R, Yach D. Globalisation and the prevention and control of non-communicable disease: the neglected chronic diseases of adults. Lancet 2003; 362:903-908.
2. Forrester T, Cooper RS, Weatherall D. Emergence of western diseases in the tropical world: The experience with chronic cardiovascular diseases. Br Med Bull 1998; 54:463-473.
3. Walker RW, McLarty DG, Kitange HM, Whiting D, Masuki G, Mtasiwa DM, et al. Stroke mortality in urban and rural Tanzania. Lancet 2000; 355:1684-1687.
4. Adler A, Amoah A, Bhumiswasdi V, Cockram C, Cooper R, Damasceno A, et al. Integrated management of cardiovascular risk. Geneva: World Health Organization; 2002.
5. Cooper R, Rotimi C, Kaufman J, Muna W, Osotimehin B. Hypertension treatment and control in sub-Saharan Africa: Defining the epidemiologic basis for policy. BMJ 1998; 316:614-617.
6. PanAmerican Health Organization. Health in the Americas: 2002 edition. Washington, DC: PAHO; 2004. Technical and Scientific Publication No. 587.
7. Ordunez-Garcia P, Espinosa-Brito AD, Cooper RS, Kaufman J, Nieto FJ. Hypertension in Cuba: Evidence of a narrow black-white difference. J Hum Hypertens 1998; 12:111-116.
8. PanAmerican Health Organization. Program on non-communicable diseases. Networking for the surveillance of risk factors for non-communicable diseases in Latin America and the Caribbean. Washington, DC: PAHO; 1999. Publication PAHO/HCP/HCN/99.05. [Questionnaire available at http://www.paho.org.]
9. Ataman SL, Cooper R, Rotimi C, McGee D, Osotimehin B, Kadiri S, et al. Standardization of blood pressure measurement in an international comparative study. J Clin Epidemiol 1996; 49:869-877.
10. Ministry of Public Health. National program for prevention, diagnosis, evaluation and control of arterial hypertension. Havana, Cuba, 1998 [in Spanish].
11. Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. National High Blood Pressure Education Program. Bethesda, Maryland: NIH, NHLBI; 1997. Publication no. 98-4080.
12. Wolf-Maier K, Kramer H, Cooper RS, Banegas JR, Giampaoli S, Hense H, et al. for the International Collaborative Group on Hypertension. Hypertension treatment and control in five European countries, Canada and the U.S. Hypertension 2004; 43:10-17.
13. Ezzati M, Hoorn SV, Rodgers A, Lopez AD, Mathers CD, Murray CJ. Comparative Risk Assessment Group. Estimates of global and regional potential health gains from reducing multiple major risk factors. Lancet 2003; 362:271-280.
14. Kaufman JS, Rotimi CN, Brieger WO, Oladokun MA, Osotimehin B, Kadiri S, et al. The mortality risk associated with hypertension: Preliminary results of a prospective study in rural Nigeria. J Hum Hypertens 1996; 10:461-464.
15. Fuentes R, Ilmaniemi N, Laurikainen F, Tuomilehto J, Nissinen A. Hypertension in developing economies: a review of population-based studies carried out from 1980 to 1998. J Hypertens 2000; 18:521-529.
16. Ordunez P, Silva LC, Rodriguez MP, Robles S. Prevalence estimates for hypertension in Latin America and the Caribbean: are they useful for surveillance? Rev Panam Salud Publica/Pan Am J Public Health 2001; 10:226-231.
17. Burt VL, Cutler JA, Higgins M, Moran MJ, Labarthe D, Whelton P, et al. Trends in the prevalence, awareness, treatment and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. Hypertension 1995; 26:60-69.
18. Cooper RS, Ordunez P, Ferrer MDI, Munoz JLB, Espinosa-Brito A. Cardiovascular disease and associated risk factors in Cuba: Prospects for prevention and control. Am J Public Health 2006; 96:94-101.
19. Ordunez P, Munoz JLB, Espinoza-Brito A, Silva LC, Cooper RS. Ethnicity, education and blood pressure in Cuba. Am J Epidemiol 2005 162:49-56.
20. Editorial. Embargoes that endanger health. BMJ 1997; 315:1393-1394.
21. Espinosa-Brito AD. Free flow of ideas and knowledge among scientists from all over the world. Rapid Response to Owen Dyer US societies to defy ban on editing articles from embargoed countries. BMJ 2004; 328:543-b.
22. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288:2981-2997.
23. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med 2001; 345:479-486.
24. Ministry of Public Health. Annual statistical report on health. Havana, Cuba 2003 [in Spanish].